Vaxart names Kevin Finney, James Breitmeyer as board committee chairs

PUBT · 1d ago
Vaxart names Kevin Finney, James Breitmeyer as board committee chairs
  • Vaxart reorganized its Nominating and Governance Committee, Compensation Committee, effective Aug. 1, 2026.
  • Kevin P. Finney named chair of the Nominating and Governance Committee.
  • James B. Breitmeyer, M.D., Ph.D. named chair of the Compensation Committee.
  • Committee rosters reshuffled, including David Wheadon, M.D., Elaine J. Heron, Ph.D., W. Mark Watson.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vaxart Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-024560), on July 28, 2026, and is solely responsible for the information contained therein.